You are leaving this site!
By clicking YES, you will be directed to another website. Click NO to remain on this page. Do you wish to continue to another website?
ADMA ADvantage Ig PROVIDES RESOURCES TO HELP TO MAKE SAVINGS AND SUPPORT SIMPLE
Enroll your patients today!
DISEASE AWARENESS INFORMATION
FREQUENTLY ASKED QUESTIONS
INFORMATION ON MANAGEMENT OF PI
INFORMATION FOR YOUR PATIENTS
LEARN MORE ABOUT PI RESEARCH
This information is being provided for your reference only. ADMA Biologics is not affiliated with and does not endorse any of the organizations listed above.
*Safety and efficacy of BIVIGAM has not been established in pediatric patients.
BIVIGAM is an Immune Globulin Intravenous (Human), 10% Liquid, indicated for the treatment of patients with primary humoral immunodeficiency (PI). This includes, but is not limited to, the humoral immune defect in common variable immunodeficiency (CVID), X linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies (SCID).
WARNING: THROMBOSIS, RENAL DYSFUNCTION, AND ACUTE RENAL FAILURE